Company intelligence / Profile preview

CrossLife Technologies

Carlsbad, California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

CrossLife Technologies develops and commercializes innovative molecular diagnostic tools using proprietary DNA/RNA-based technologies. Their platforms enable rapid, point-of-care detection of infectious and noncommunicable diseases with minimal sample preparation and without PCR amplification. The company holds patents in engineered aptamers for molecular biology applications. Products are designed to be low-cost, efficient, and suitable for use outside traditional laboratory settings.

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: Aptamer (based on patent filings for engineered aptamers)DNA/RNA-based diagnosticsMolecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on CrossLife Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CrossLife Technologies.

Explore the full profile